J. Hickok

发表

Nausea and emesis: evidence for a biobehavioral perspective

P. Andrews, G. Morrow, J. Roscoe, 2002, Supportive Care in Cancer.

Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer.

G. Morrow, J. Roscoe, J. Hickok, 2005, Journal of pain and symptom management.

Biobehavioral factors in chemotherapy-induced nausea and vomiting.

G. Morrow, J. Roscoe, J. Hickok, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer.

J. Griggs, G. Morrow, J. Roscoe, 2005, Journal of pain and symptom management.

Vagal changes following cancer chemotherapy: implications for the development of nausea.

R. Stern, P. Andrews, G. Morrow, 2000, Psychophysiology.

Community-based clinical oncology research trials for cancer-related fatigue.

P. Jean-Pierre, G. Morrow, J. Roscoe, 2006, The journal of supportive oncology.

Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea?

R. Stern, P. Andrews, G. Morrow, 2002, Psychophysiology.

Pegfilgrastim-induced bone pain: incidence, risk factors, and management in a community practice

J. Hickok, M. Hofman, J. Kirshner, 2007 .

The role of patients' expectations in the development of anticipatory nausea related to chemotherapy for cancer.

G. Morrow, J. Roscoe, J. Hickok, 2001, Journal of pain and symptom management.

Progress in reducing nausea and emesis. Comparisons of ondansetron (zofran), granisetron (kytril), and tropisetron (navoban)

G. Morrow, J. Hickok, S. Rosenthal, 1995, Cancer.

Sources of information used by patients to learn about chemotherapy side effects.

G. Morrow, J. Roscoe, J. Hickok, 2000, Journal of cancer education : the official journal of the American Association for Cancer Education.

The role of behavioral conditioning in the development of nausea.

G. Morrow, J. Roscoe, J. Hickok, 2002, American journal of obstetrics and gynecology.

5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial.

S. Dakhil, T. Fitch, G. Morrow, 2005, The Lancet. Oncology.

Fatigue associated with cancer and its treatment

P. Andrews, G. Morrow, J. Roscoe, 2002, Supportive Care in Cancer.

Management of Cancer-Related Fatigue

G. Morrow, J. Roscoe, J. Hickok, 2005, Cancer investigation.

Frequency and clinical implications of delayed nausea and delayed emesis.

G. Morrow, J. Hickok, T. Burish, 1996, American journal of clinical oncology.

The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study.

D. Moore, P. Flynn, J. Atkins, 2003, Journal of pain and symptom management.

A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study.

G. Morrow, J. Roscoe, J. Hickok, 2007, Supportive cancer therapy.

Patient expectations as predictor of chemotherapy-induced nausea

G. Morrow, J. Roscoe, J. Hickok, 2000, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Ginger for chemotherapy-related nausea in cancer patients: A URCC CCOP randomized, double-blind, placebo-controlled clinical trial of 644 cancer patients.

C. Heckler, S. Dakhil, P. Flynn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5‐hydroxytryptamine‐3 antiemetics

J. Atkins, T. Fitch, G. Morrow, 2003, Cancer.

Initial control of chemotherapy-induced nausea and vomiting in patient quality of life.

R. Stern, G. Morrow, J. Roscoe, 1998, Oncology.

Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices.

R. Stern, G. Morrow, J. Roscoe, 2000, Journal of pain and symptom management.

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients

C. Heckler, S. Dakhil, P. Flynn, 2012, Supportive Care in Cancer.

Use of 5‐HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings

R. Stern, P. Flynn, G. Morrow, 1999 .

Behavioral aspects of clinical trials: An integrated framework from behavior theory

G. Morrow, J. Hickok, T. Burish, 1994, Cancer.

Effect of paroxetine hydrochloride (Paxil®) on fatigue and depression in breast cancer patients receiving chemotherapy

J. Griggs, G. Morrow, J. Roscoe, 2005, Breast Cancer Research and Treatment.

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program.

P. Flynn, P. Andrews, R. Raubertas, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected.

P. Jean-Pierre, B. Issell, G. Morrow, 2006, Journal of the Society for Integrative Oncology.

Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: implications for management.

S. McDonald, G. Morrow, J. Hickok, 1996, Journal of pain and symptom management.

Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations

L. Colman, G. Morrow, J. Hickok, 2007, British Journal of Cancer.

Patient expectation is a strong predictor of severe nausea after chemotherapy

G. Morrow, J. Roscoe, J. Hickok, 2004, Cancer.

Cancer patients' expectations of experiencing treatment‐related side effects

Dennis F. Moore, T. Fitch, G. Morrow, 2004, Cancer.

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial

T. Sweeney, P. Flynn, K. Pandya, 2005, The Lancet.

Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer

G. Morrow, J. Roscoe, J. Hickok, 2005, Cancer.

Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach.

Youngmee Kim, G. Morrow, J. Hickok, 2006, Journal of pain and symptom management.

Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment

P. Andrews, G. Morrow, J. Roscoe, 2002, Supportive Care in Cancer.

The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed

J. Griggs, G. Morrow, J. Roscoe, 2005 .

Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea.

S. Lipshultz, G. Morrow, J. Hickok, 1999, Journal of the autonomic nervous system.

A preliminary report of a double blind placebo controlled trial of gabapentin for control of hot flashes in women with breast cancer. A University of Rochester Cancer Center CCOP study.

J. Roscoe, P. Flynn, K. Pandya, 2004, Journal of Clinical Oncology.

Occurrence, severity and longitudinal course of symptoms in 1129 patients during radiation therapy

G. Morrow, J. Roscoe, J. Hickok, 2005 .